nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.144	0.222	CbGbCtD
Sulfamethoxazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.101	0.155	CbGbCtD
Sulfamethoxazole—CYP2C8—Progesterone—uterine cancer	0.0955	0.147	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—uterine cancer	0.0741	0.114	CbGbCtD
Sulfamethoxazole—CYP2C9—Progesterone—uterine cancer	0.0666	0.102	CbGbCtD
Sulfamethoxazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0585	0.09	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—uterine cancer	0.0428	0.0658	CbGbCtD
Sulfamethoxazole—CYP3A4—Progesterone—uterine cancer	0.0387	0.0596	CbGbCtD
Sulfamethoxazole—CYP3A4—Etoposide—uterine cancer	0.0173	0.0267	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—uterine cancer	0.0118	0.0182	CbGbCtD
Sulfamethoxazole—NAT1—myometrium—uterine cancer	0.00958	0.101	CbGeAlD
Sulfamethoxazole—NAT2—renal system—uterine cancer	0.00767	0.0809	CbGeAlD
Sulfamethoxazole—NAT1—uterine cervix—uterine cancer	0.00746	0.0787	CbGeAlD
Sulfamethoxazole—NAT1—decidua—uterine cancer	0.00711	0.075	CbGeAlD
Sulfamethoxazole—NAT1—endometrium—uterine cancer	0.00675	0.0712	CbGeAlD
Sulfamethoxazole—NAT1—mammalian vulva—uterine cancer	0.00653	0.0689	CbGeAlD
Sulfamethoxazole—NAT1—female reproductive system—uterine cancer	0.00559	0.059	CbGeAlD
Sulfamethoxazole—NAT1—female gonad—uterine cancer	0.00508	0.0537	CbGeAlD
Sulfamethoxazole—NAT1—vagina—uterine cancer	0.00505	0.0533	CbGeAlD
Sulfamethoxazole—PTGS1—oviduct—uterine cancer	0.00468	0.0493	CbGeAlD
Sulfamethoxazole—UGT1A9—renal system—uterine cancer	0.00414	0.0437	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—uterine cancer	0.00327	0.0345	CbGeAlD
Sulfamethoxazole—PTGS1—artery—uterine cancer	0.0031	0.0327	CbGeAlD
Sulfamethoxazole—Sulfathiazole—CYP19A1—uterine cancer	0.00185	1	CrCbGaD
Sulfamethoxazole—CYP2C8—renal system—uterine cancer	0.00134	0.0142	CbGeAlD
Sulfamethoxazole—CYP2C8—endometrium—uterine cancer	0.0013	0.0137	CbGeAlD
Sulfamethoxazole—PTGS1—epithelium—uterine cancer	0.00117	0.0124	CbGeAlD
Sulfamethoxazole—PTGS1—uterine cervix—uterine cancer	0.00116	0.0123	CbGeAlD
Sulfamethoxazole—PTGS1—smooth muscle tissue—uterine cancer	0.00113	0.0119	CbGeAlD
Sulfamethoxazole—PTGS1—renal system—uterine cancer	0.00109	0.0115	CbGeAlD
Sulfamethoxazole—CYP2C8—female reproductive system—uterine cancer	0.00108	0.0114	CbGeAlD
Sulfamethoxazole—PTGS1—endometrium—uterine cancer	0.00105	0.0111	CbGeAlD
Sulfamethoxazole—PTGS1—mammalian vulva—uterine cancer	0.00102	0.0107	CbGeAlD
Sulfamethoxazole—CYP2C8—vagina—uterine cancer	0.000973	0.0103	CbGeAlD
Sulfamethoxazole—PTGS1—uterus—uterine cancer	0.00097	0.0102	CbGeAlD
Sulfamethoxazole—CYP2C9—female reproductive system—uterine cancer	0.000955	0.0101	CbGeAlD
Sulfamethoxazole—CYP3A4—renal system—uterine cancer	0.00091	0.0096	CbGeAlD
Sulfamethoxazole—ALB—lymph node—uterine cancer	0.000895	0.00945	CbGeAlD
Sulfamethoxazole—PTGS1—female reproductive system—uterine cancer	0.000872	0.00921	CbGeAlD
Sulfamethoxazole—PTGS1—female gonad—uterine cancer	0.000794	0.00838	CbGeAlD
Sulfamethoxazole—PTGS1—vagina—uterine cancer	0.000789	0.00833	CbGeAlD
Sulfamethoxazole—CYP3A4—female reproductive system—uterine cancer	0.000729	0.00769	CbGeAlD
Sulfamethoxazole—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00064	0.00296	CcSEcCtD
Sulfamethoxazole—Oliguria—Epirubicin—uterine cancer	0.000634	0.00293	CcSEcCtD
Sulfamethoxazole—Glossitis—Epirubicin—uterine cancer	0.000634	0.00293	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Progesterone—uterine cancer	0.000632	0.00292	CcSEcCtD
Sulfamethoxazole—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000628	0.0029	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Progesterone—uterine cancer	0.000628	0.0029	CcSEcCtD
Sulfamethoxazole—Fatigue—Progesterone—uterine cancer	0.000627	0.00289	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Etoposide—uterine cancer	0.000621	0.00287	CcSEcCtD
Sulfamethoxazole—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000616	0.00284	CcSEcCtD
Sulfamethoxazole—Neutropenia—Etoposide—uterine cancer	0.000612	0.00282	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0006	0.00277	CcSEcCtD
Sulfamethoxazole—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00275	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Progesterone—uterine cancer	0.000595	0.00275	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000588	0.00271	CcSEcCtD
Sulfamethoxazole—Oliguria—Doxorubicin—uterine cancer	0.000587	0.00271	CcSEcCtD
Sulfamethoxazole—Glossitis—Doxorubicin—uterine cancer	0.000587	0.00271	CcSEcCtD
Sulfamethoxazole—Pneumonia—Etoposide—uterine cancer	0.000587	0.00271	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Etoposide—uterine cancer	0.000583	0.00269	CcSEcCtD
Sulfamethoxazole—Infestation—Etoposide—uterine cancer	0.000583	0.00269	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00058	0.00268	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000578	0.00267	CcSEcCtD
Sulfamethoxazole—Urticaria—Progesterone—uterine cancer	0.000578	0.00267	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Progesterone—uterine cancer	0.000575	0.00265	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Progesterone—uterine cancer	0.000575	0.00265	CcSEcCtD
Sulfamethoxazole—Hyperkalaemia—Epirubicin—uterine cancer	0.000574	0.00265	CcSEcCtD
Sulfamethoxazole—Renal failure—Etoposide—uterine cancer	0.000573	0.00265	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000573	0.00264	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Etoposide—uterine cancer	0.000572	0.00264	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000569	0.00263	CcSEcCtD
Sulfamethoxazole—Stomatitis—Etoposide—uterine cancer	0.000569	0.00262	CcSEcCtD
Sulfamethoxazole—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000568	0.00262	CcSEcCtD
Sulfamethoxazole—Leukopenia—Dactinomycin—uterine cancer	0.000564	0.0026	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Etoposide—uterine cancer	0.000552	0.00255	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Epirubicin—uterine cancer	0.000549	0.00253	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Etoposide—uterine cancer	0.000544	0.00251	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000539	0.00249	CcSEcCtD
Sulfamethoxazole—Myalgia—Dactinomycin—uterine cancer	0.000536	0.00248	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Progesterone—uterine cancer	0.000536	0.00247	CcSEcCtD
Sulfamethoxazole—Hyperkalaemia—Doxorubicin—uterine cancer	0.000531	0.00245	CcSEcCtD
Sulfamethoxazole—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000524	0.00242	CcSEcCtD
Sulfamethoxazole—Asthenia—Progesterone—uterine cancer	0.000522	0.00241	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00241	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00241	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Etoposide—uterine cancer	0.000517	0.00239	CcSEcCtD
Sulfamethoxazole—Pruritus—Progesterone—uterine cancer	0.000515	0.00238	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Etoposide—uterine cancer	0.000513	0.00237	CcSEcCtD
Sulfamethoxazole—PTGS1—lymph node—uterine cancer	0.00051	0.00539	CbGeAlD
Sulfamethoxazole—Aplastic anaemia—Doxorubicin—uterine cancer	0.000508	0.00234	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dactinomycin—uterine cancer	0.000503	0.00232	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Progesterone—uterine cancer	0.000498	0.0023	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Etoposide—uterine cancer	0.000495	0.00229	CcSEcCtD
Sulfamethoxazole—Anorexia—Dactinomycin—uterine cancer	0.00049	0.00226	CcSEcCtD
Sulfamethoxazole—Eye disorder—Etoposide—uterine cancer	0.000489	0.00226	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00224	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Epirubicin—uterine cancer	0.000483	0.00223	CcSEcCtD
Sulfamethoxazole—Dizziness—Progesterone—uterine cancer	0.000481	0.00222	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Epirubicin—uterine cancer	0.000474	0.00219	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Etoposide—uterine cancer	0.000473	0.00218	CcSEcCtD
Sulfamethoxazole—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000473	0.00218	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Etoposide—uterine cancer	0.000472	0.00218	CcSEcCtD
Sulfamethoxazole—Chills—Etoposide—uterine cancer	0.00047	0.00217	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000468	0.00216	CcSEcCtD
Sulfamethoxazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000466	0.00215	CcSEcCtD
Sulfamethoxazole—Vomiting—Progesterone—uterine cancer	0.000462	0.00213	CcSEcCtD
Sulfamethoxazole—Rash—Progesterone—uterine cancer	0.000459	0.00212	CcSEcCtD
Sulfamethoxazole—Dermatitis—Progesterone—uterine cancer	0.000458	0.00211	CcSEcCtD
Sulfamethoxazole—Headache—Progesterone—uterine cancer	0.000456	0.0021	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000451	0.00208	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00045	0.00208	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Doxorubicin—uterine cancer	0.000447	0.00206	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dactinomycin—uterine cancer	0.000447	0.00206	CcSEcCtD
Sulfamethoxazole—Renal impairment—Epirubicin—uterine cancer	0.000446	0.00206	CcSEcCtD
Sulfamethoxazole—Fatigue—Dactinomycin—uterine cancer	0.000443	0.00205	CcSEcCtD
Sulfamethoxazole—Purpura—Epirubicin—uterine cancer	0.00044	0.00203	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Doxorubicin—uterine cancer	0.000439	0.00203	CcSEcCtD
Sulfamethoxazole—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000436	0.00201	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Epirubicin—uterine cancer	0.000435	0.00201	CcSEcCtD
Sulfamethoxazole—Nausea—Progesterone—uterine cancer	0.000432	0.00199	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Epirubicin—uterine cancer	0.000426	0.00197	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00042	0.00194	CcSEcCtD
Sulfamethoxazole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000419	0.00193	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000416	0.00192	CcSEcCtD
Sulfamethoxazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000416	0.00192	CcSEcCtD
Sulfamethoxazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.00192	CcSEcCtD
Sulfamethoxazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00191	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—uterine cancer	0.000413	0.0019	CcSEcCtD
Sulfamethoxazole—Vertigo—Etoposide—uterine cancer	0.00041	0.00189	CcSEcCtD
Sulfamethoxazole—Leukopenia—Etoposide—uterine cancer	0.000408	0.00188	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—uterine cancer	0.000407	0.00188	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—uterine cancer	0.000406	0.00188	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—uterine cancer	0.000406	0.00188	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—uterine cancer	0.000402	0.00186	CcSEcCtD
Sulfamethoxazole—Ataxia—Epirubicin—uterine cancer	0.000399	0.00184	CcSEcCtD
Sulfamethoxazole—Cough—Etoposide—uterine cancer	0.000398	0.00184	CcSEcCtD
Sulfamethoxazole—Convulsion—Etoposide—uterine cancer	0.000395	0.00182	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—uterine cancer	0.000394	0.00182	CcSEcCtD
Sulfamethoxazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000391	0.00181	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000385	0.00178	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000382	0.00176	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—uterine cancer	0.000379	0.00175	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—uterine cancer	0.000372	0.00172	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—uterine cancer	0.000369	0.0017	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—uterine cancer	0.000369	0.0017	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Etoposide—uterine cancer	0.000364	0.00168	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Epirubicin—uterine cancer	0.000363	0.00168	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—uterine cancer	0.000361	0.00167	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Epirubicin—uterine cancer	0.00036	0.00166	CcSEcCtD
Sulfamethoxazole—Anorexia—Etoposide—uterine cancer	0.000355	0.00164	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000354	0.00163	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—uterine cancer	0.000352	0.00162	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—uterine cancer	0.000348	0.00161	CcSEcCtD
Sulfamethoxazole—Neutropenia—Epirubicin—uterine cancer	0.000343	0.00158	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—uterine cancer	0.000336	0.00155	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—uterine cancer	0.000335	0.00155	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—uterine cancer	0.000333	0.00154	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—uterine cancer	0.000332	0.00153	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—uterine cancer	0.000329	0.00152	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—uterine cancer	0.000327	0.00151	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—uterine cancer	0.000327	0.00151	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—uterine cancer	0.000327	0.00151	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000324	0.0015	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—uterine cancer	0.000324	0.0015	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—uterine cancer	0.000323	0.00149	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—uterine cancer	0.000322	0.00149	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—uterine cancer	0.000321	0.00148	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—uterine cancer	0.000321	0.00148	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—uterine cancer	0.000321	0.00148	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000321	0.00148	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—uterine cancer	0.000319	0.00147	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—uterine cancer	0.000317	0.00146	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00031	0.00143	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—uterine cancer	0.000309	0.00143	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—uterine cancer	0.000305	0.00141	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—uterine cancer	0.000305	0.00141	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—uterine cancer	0.000304	0.0014	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—uterine cancer	0.000304	0.0014	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—uterine cancer	0.000303	0.0014	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—uterine cancer	0.000303	0.0014	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.0003	0.00138	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—uterine cancer	0.000297	0.00137	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000297	0.00137	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—uterine cancer	0.000296	0.00136	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—uterine cancer	0.000295	0.00136	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—uterine cancer	0.000294	0.00136	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—uterine cancer	0.000294	0.00136	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—uterine cancer	0.000294	0.00136	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—uterine cancer	0.00029	0.00134	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—uterine cancer	0.000288	0.00133	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—uterine cancer	0.000288	0.00133	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000286	0.00132	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000282	0.0013	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—uterine cancer	0.000278	0.00128	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—uterine cancer	0.000274	0.00127	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—uterine cancer	0.000274	0.00127	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—uterine cancer	0.000274	0.00126	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—uterine cancer	0.000272	0.00125	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—uterine cancer	0.000268	0.00124	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—uterine cancer	0.000267	0.00123	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—uterine cancer	0.000267	0.00123	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—uterine cancer	0.000266	0.00123	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—uterine cancer	0.000265	0.00122	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—uterine cancer	0.000265	0.00122	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—uterine cancer	0.000263	0.00122	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—uterine cancer	0.000263	0.00122	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—uterine cancer	0.000257	0.00119	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—uterine cancer	0.000257	0.00119	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—uterine cancer	0.000256	0.00118	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—uterine cancer	0.000255	0.00118	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—uterine cancer	0.000254	0.00117	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—uterine cancer	0.000253	0.00117	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—uterine cancer	0.000251	0.00116	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—uterine cancer	0.000248	0.00115	CcSEcCtD
Sulfamethoxazole—Dizziness—Etoposide—uterine cancer	0.000246	0.00114	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—uterine cancer	0.000245	0.00113	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—uterine cancer	0.000245	0.00113	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—uterine cancer	0.000244	0.00113	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—uterine cancer	0.000238	0.0011	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—uterine cancer	0.000237	0.00109	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—uterine cancer	0.000236	0.00109	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—uterine cancer	0.000235	0.00108	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—uterine cancer	0.000234	0.00108	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—uterine cancer	0.000233	0.00108	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—uterine cancer	0.000232	0.00107	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—uterine cancer	0.00023	0.00106	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—uterine cancer	0.00023	0.00106	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—uterine cancer	0.000229	0.00106	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—uterine cancer	0.000223	0.00103	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—uterine cancer	0.000221	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—uterine cancer	0.000221	0.00102	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—uterine cancer	0.000218	0.001	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—uterine cancer	0.000218	0.001	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000216	0.000997	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—uterine cancer	0.000212	0.000981	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—uterine cancer	0.000212	0.000977	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—uterine cancer	0.000209	0.000963	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—uterine cancer	0.000206	0.000952	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—uterine cancer	0.000205	0.000946	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—uterine cancer	0.000205	0.000944	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000204	0.000943	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—uterine cancer	0.000203	0.000935	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—uterine cancer	0.000201	0.000929	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—uterine cancer	0.000201	0.000929	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.0002	0.000923	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—uterine cancer	0.000199	0.000918	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000194	0.00531	CbGpPWpGaD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—uterine cancer	0.000193	0.000891	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00019	0.000877	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—uterine cancer	0.000189	0.000874	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	0.000189	0.00517	CbGpPWpGaD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000189	0.000872	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—AKR1C3—uterine cancer	0.000189	0.00516	CbGpPWpGaD
Sulfamethoxazole—Insomnia—Epirubicin—uterine cancer	0.000189	0.000871	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—uterine cancer	0.000187	0.000865	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—uterine cancer	0.000186	0.000858	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—uterine cancer	0.000184	0.000849	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—uterine cancer	0.000184	0.000847	CcSEcCtD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000182	0.00498	CbGpPWpGaD
Sulfamethoxazole—Decreased appetite—Epirubicin—uterine cancer	0.000181	0.000837	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00018	0.000831	CcSEcCtD
Sulfamethoxazole—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00018	0.00492	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00018	0.00492	CbGpPWpGaD
Sulfamethoxazole—Fatigue—Epirubicin—uterine cancer	0.00018	0.00083	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—CYP19A1—uterine cancer	0.000176	0.00482	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—STK11—uterine cancer	0.000176	0.00482	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	0.000176	0.00481	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000176	0.000812	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—uterine cancer	0.000175	0.000806	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—uterine cancer	0.000172	0.000794	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000171	0.00467	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—uterine cancer	0.000171	0.000787	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—uterine cancer	0.00017	0.000784	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—uterine cancer	0.000168	0.000774	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000167	0.000769	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—AKR1B1—uterine cancer	0.000166	0.00455	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—STAR—uterine cancer	0.000166	0.00455	CbGpPWpGaD
Sulfamethoxazole—Fatigue—Doxorubicin—uterine cancer	0.000166	0.000768	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—uterine cancer	0.000166	0.000765	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP11A1—uterine cancer	0.000165	0.00452	CbGpPWpGaD
Sulfamethoxazole—Abdominal pain—Epirubicin—uterine cancer	0.000165	0.000761	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—uterine cancer	0.000165	0.000761	CcSEcCtD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000164	0.00447	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000158	0.000728	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000156	0.00427	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—MTHFR—uterine cancer	0.000155	0.00424	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000154	0.00421	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Epirubicin—uterine cancer	0.000154	0.000709	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—uterine cancer	0.000153	0.000708	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—uterine cancer	0.000153	0.000704	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—uterine cancer	0.000153	0.000704	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—uterine cancer	0.00015	0.000691	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—CYP19A1—uterine cancer	0.000149	0.00408	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000148	0.00406	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000148	0.00404	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Epirubicin—uterine cancer	0.000148	0.000681	CcSEcCtD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000147	0.00402	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000147	0.00401	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000146	0.004	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000143	0.00391	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Epirubicin—uterine cancer	0.000143	0.000659	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—uterine cancer	0.000142	0.000656	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—uterine cancer	0.000138	0.000639	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—uterine cancer	0.000138	0.000637	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—uterine cancer	0.000137	0.00063	CcSEcCtD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000133	0.00364	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—MTHFR—uterine cancer	0.000133	0.00362	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Epirubicin—uterine cancer	0.000133	0.000612	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—uterine cancer	0.000132	0.00061	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—uterine cancer	0.000132	0.000607	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—uterine cancer	0.000131	0.000606	CcSEcCtD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000131	0.00359	CbGpPWpGaD
Sulfamethoxazole—Headache—Epirubicin—uterine cancer	0.000131	0.000603	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—POLD1—uterine cancer	0.000131	0.00357	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00013	0.00355	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00013	0.00355	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	0.000129	0.00353	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Doxorubicin—uterine cancer	0.000128	0.000589	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000126	0.00345	CbGpPWpGaD
Sulfamethoxazole—Nausea—Epirubicin—uterine cancer	0.000124	0.000572	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—uterine cancer	0.000123	0.000566	CcSEcCtD
Sulfamethoxazole—NAT2—Metabolism—AKR1C1—uterine cancer	0.000122	0.00334	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000122	0.00334	CbGpPWpGaD
Sulfamethoxazole—Rash—Doxorubicin—uterine cancer	0.000122	0.000562	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—uterine cancer	0.000122	0.000561	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000122	0.00332	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000121	0.00332	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000121	0.00331	CbGpPWpGaD
Sulfamethoxazole—Headache—Doxorubicin—uterine cancer	0.000121	0.000558	CcSEcCtD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00012	0.00329	CbGpPWpGaD
Sulfamethoxazole—Nausea—Doxorubicin—uterine cancer	0.000115	0.000529	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.000113	0.0031	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—RRM2—uterine cancer	0.000109	0.00298	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000108	0.00295	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	0.000107	0.00292	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000106	0.0029	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000106	0.0029	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—DCN—uterine cancer	0.000106	0.00289	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	0.000105	0.00288	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000105	0.00287	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000102	0.00278	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.0001	0.00274	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP11A1—uterine cancer	9.96e-05	0.00272	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	9.94e-05	0.00272	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—CCL2—uterine cancer	9.88e-05	0.0027	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.79e-05	0.00267	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.66e-05	0.00264	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.55e-05	0.00261	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.47e-05	0.00259	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.44e-05	0.00258	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.42e-05	0.00257	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKR1C3—uterine cancer	9.41e-05	0.00257	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	9.23e-05	0.00252	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	8.69e-05	0.00237	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	8.57e-05	0.00234	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—EP300—uterine cancer	8.5e-05	0.00232	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	8.32e-05	0.00227	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	8.09e-05	0.00221	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SRD5A2—uterine cancer	8.01e-05	0.00219	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NDUFB11—uterine cancer	8.01e-05	0.00219	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.93e-05	0.00217	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	7.85e-05	0.00215	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	7.85e-05	0.00214	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	7.78e-05	0.00213	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.78e-05	0.00213	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	7.74e-05	0.00212	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.71e-05	0.00211	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTEN—uterine cancer	7.38e-05	0.00202	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.35e-05	0.00201	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—STK11—uterine cancer	7.33e-05	0.002	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP19A1—uterine cancer	7.33e-05	0.002	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—EP300—uterine cancer	7.04e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.93e-05	0.00189	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.85e-05	0.00187	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.85e-05	0.00187	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.81e-05	0.00186	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.81e-05	0.00186	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SRD5A2—uterine cancer	6.53e-05	0.00179	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NDUFB11—uterine cancer	6.53e-05	0.00179	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.48e-05	0.00177	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	6.39e-05	0.00175	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.34e-05	0.00173	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	6.3e-05	0.00172	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.08e-05	0.00166	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.99e-05	0.00164	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKR1B1—uterine cancer	5.79e-05	0.00158	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—STAR—uterine cancer	5.79e-05	0.00158	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	5.73e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.73e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.73e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.65e-05	0.00154	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	5.6e-05	0.00153	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.57e-05	0.00152	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.57e-05	0.00152	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—MTHFR—uterine cancer	5.51e-05	0.00151	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—uterine cancer	5.44e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.34e-05	0.00146	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CA—uterine cancer	5.2e-05	0.00142	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	5.18e-05	0.00142	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.03e-05	0.00137	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5e-05	0.00137	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—uterine cancer	4.79e-05	0.00131	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKR1B1—uterine cancer	4.72e-05	0.00129	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—STAR—uterine cancer	4.72e-05	0.00129	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.67e-05	0.00128	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POLD1—uterine cancer	4.55e-05	0.00124	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKR1C1—uterine cancer	4.25e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—AKT1—uterine cancer	4.25e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SRD5A2—uterine cancer	4.22e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NDUFB11—uterine cancer	4.22e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.21e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IRF1—uterine cancer	4.2e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NDUFB11—uterine cancer	4.19e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SRD5A2—uterine cancer	4.19e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.16e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.1e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.09e-05	0.00112	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.07e-05	0.00111	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.87e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.85e-05	0.00105	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—RRM2—uterine cancer	3.79e-05	0.00104	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POLD1—uterine cancer	3.71e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—DCN—uterine cancer	3.68e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKR1C1—uterine cancer	3.47e-05	0.000947	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP11A1—uterine cancer	3.47e-05	0.000947	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.43e-05	0.000938	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.43e-05	0.000938	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.34e-05	0.000912	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKR1C3—uterine cancer	3.27e-05	0.000895	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.15e-05	0.000861	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—RRM2—uterine cancer	3.09e-05	0.000844	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—uterine cancer	3.06e-05	0.000837	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKR1B1—uterine cancer	3.05e-05	0.000834	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—STAR—uterine cancer	3.05e-05	0.000834	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKR1B1—uterine cancer	3.03e-05	0.000829	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—STAR—uterine cancer	3.03e-05	0.000829	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.01e-05	0.000824	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—DCN—uterine cancer	3e-05	0.00082	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3e-05	0.000819	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—EP300—uterine cancer	2.92e-05	0.000798	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP11A1—uterine cancer	2.83e-05	0.000772	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKR1C3—uterine cancer	2.67e-05	0.000729	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP19A1—uterine cancer	2.55e-05	0.000697	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—STK11—uterine cancer	2.55e-05	0.000697	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.48e-05	0.000678	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—STAR—uterine cancer	2.48e-05	0.000678	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.45e-05	0.000671	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.41e-05	0.000659	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.39e-05	0.000654	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POLD1—uterine cancer	2.39e-05	0.000654	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POLD1—uterine cancer	2.38e-05	0.00065	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.28e-05	0.000624	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.26e-05	0.000619	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.26e-05	0.000619	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKR1C1—uterine cancer	2.24e-05	0.000612	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKR1C1—uterine cancer	2.23e-05	0.000608	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—uterine cancer	2.16e-05	0.000591	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—STK11—uterine cancer	2.08e-05	0.000568	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP19A1—uterine cancer	2.08e-05	0.000568	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RRM2—uterine cancer	2e-05	0.000545	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RRM2—uterine cancer	1.98e-05	0.000542	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.95e-05	0.000533	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POLD1—uterine cancer	1.95e-05	0.000532	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—DCN—uterine cancer	1.94e-05	0.000529	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—DCN—uterine cancer	1.93e-05	0.000526	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—MTHFR—uterine cancer	1.92e-05	0.000524	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.88e-05	0.000515	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.86e-05	0.000509	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.83e-05	0.000499	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.82e-05	0.000498	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP11A1—uterine cancer	1.81e-05	0.000496	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—uterine cancer	1.77e-05	0.000483	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.72e-05	0.000471	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKR1C3—uterine cancer	1.71e-05	0.000468	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.69e-05	0.000462	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.64e-05	0.000447	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STAR—uterine cancer	1.64e-05	0.000447	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RRM2—uterine cancer	1.62e-05	0.000444	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—DCN—uterine cancer	1.58e-05	0.000431	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—MTHFR—uterine cancer	1.56e-05	0.000427	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.54e-05	0.000421	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.49e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.4e-05	0.000383	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.38e-05	0.000376	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—STK11—uterine cancer	1.34e-05	0.000367	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.34e-05	0.000367	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—STK11—uterine cancer	1.34e-05	0.000365	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP19A1—uterine cancer	1.34e-05	0.000365	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EP300—uterine cancer	1.31e-05	0.000359	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POLD1—uterine cancer	1.28e-05	0.000351	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.26e-05	0.000344	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.25e-05	0.000343	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—uterine cancer	1.24e-05	0.00034	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NRAS—uterine cancer	1.23e-05	0.000336	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.2e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.2e-05	0.000328	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.2e-05	0.000327	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—STK11—uterine cancer	1.09e-05	0.000299	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.09e-05	0.000299	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RRM2—uterine cancer	1.07e-05	0.000293	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—uterine cancer	1.07e-05	0.000291	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—uterine cancer	1.06e-05	0.000289	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—DCN—uterine cancer	1.04e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.03e-05	0.00028	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—EP300—uterine cancer	1.02e-05	0.000278	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTHFR—uterine cancer	1.01e-05	0.000276	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTHFR—uterine cancer	1e-05	0.000274	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.8e-06	0.000268	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.78e-06	0.000267	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—uterine cancer	9.71e-06	0.000265	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—uterine cancer	9.39e-06	0.000257	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	9.25e-06	0.000253	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—uterine cancer	8.98e-06	0.000246	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.89e-06	0.000243	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.84e-06	0.000242	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—uterine cancer	8.69e-06	0.000238	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—EP300—uterine cancer	8.29e-06	0.000227	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTHFR—uterine cancer	8.21e-06	0.000224	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—uterine cancer	7.93e-06	0.000217	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—uterine cancer	7.52e-06	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.24e-06	0.000198	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—STK11—uterine cancer	7.21e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.21e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—uterine cancer	6.14e-06	0.000168	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—uterine cancer	6.13e-06	0.000168	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—uterine cancer	5.61e-06	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—uterine cancer	5.58e-06	0.000153	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTHFR—uterine cancer	5.42e-06	0.000148	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—EP300—uterine cancer	5.35e-06	0.000146	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—EP300—uterine cancer	5.32e-06	0.000145	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—uterine cancer	5.01e-06	0.000137	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—uterine cancer	4.57e-06	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—EP300—uterine cancer	4.36e-06	0.000119	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.96e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—uterine cancer	3.94e-06	0.000108	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—uterine cancer	3.23e-06	8.84e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.22e-06	8.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—uterine cancer	3.22e-06	8.79e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—uterine cancer	3.01e-06	8.23e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EP300—uterine cancer	2.87e-06	7.85e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—uterine cancer	2.63e-06	7.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.13e-06	5.81e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—uterine cancer	1.74e-06	4.75e-05	CbGpPWpGaD
